Group: Second Generation GcMAF

High Dose Second Generation Gc-MAF is produced using our new Patent Pending process which was developed here i […]

Second Generation GcMAF is made using a new and improved 2nd generation method of Gc-MAF production which is 1 […]

Our GcMAF is tested for macrophage phagocytic activity using mouse macrophages and sheep red blood cells at th […]

Second Generation GcMAF is stable for a minimum of 2 weeks at room temperature. See our Stability of GcMAF in […]

Saisei Mirai has been producing our Patented Second Generation GcMAF since 2011 and our doctors have treated o […]

We produce GcMAF in our own Saisei Mirai Cell Processing Center (CPC) in Osaka, Japan.

In addition to GcMAF we produce NK cells (which we call Hyper T/NK Cell Therapy), lymphocytes and dendritic ce […]